Mí katã míegbɔ ya sesĩe le COVID-19 ƒe atike xɔxɔ vɔ megbe, alo? Míenya be atikewɔmɔnu xɔxɔ nye mɔ nyuitɔ si dzi nàto akpɔ ɖokuiwò ta tso dɔlékuia me. Gake ɖewohĩ miese be amesiwo no atikeawo katã gɔ̃ hã gaxɔ
COVID-19 ake. Ðewohĩ edzɔ ɖe wò ŋutɔ xɔ̃wòwo alo wò ƒometɔwo dometɔ ɖeka dzi. Eyata biabia sue aɖe va susu me nam be, "Ekema viɖe aɖeke mele atikewɔmɔnua xɔxɔ me oa?" Emae nye nusi ŋu míele nu ƒom tsoe egbea be míakpɔ ŋuɖoɖo na biabia sia. Le atikewɔwɔ me la, woyɔa nɔnɔme sia be ‘Breakthrough COVID-19’ . Na míakpɔ nusi tututu esia nye ɖa.
Nuka tututue ‘Breakthrough COVID-19’ fia?
Kpuie ko la,
‘Breakthrough COVID-19’ fia be ègaxɔ COVID-19 dɔlékuia le kwasiɖa eve megbe ne èwu COVID-19 ƒe atike ƒe agbɔsɔsɔmewo katã nu. Bu eŋu ale. COVID-19 ƒe atike la le abe hehexɔxɔ na míaƒe ŋutilã ene. Efiaa míaƒe dɔlélenutsiŋutete alesi woawɔ avu kple dɔlékui sia. Le hehe sia ta la, ne dɔlékuia ge ɖe ŋutilãa me ŋutɔŋutɔ la, míaƒe ŋutilã ate ŋu anɔ te ɖe enu dzidzedzetɔe. Gake nusi wòle be nànyae nye
be atikewɔmɔnu aɖeke mele xexeame si mewɔa dɔ 100% o . Ema fia be ame ʋɛ aɖewo ŋutɔ ate ŋu axɔ dɔa ne woxɔ atike la gɔ̃ hã. Gake nu vevitɔe nye be ne èxɔ dɔa gɔ̃ hã la, dɔléle si nàxɔ tso atikewɔmɔnua me la
masẽ o . Mɔnukpɔkpɔ si li be woaxɔ ame ɖe kɔdzi kple kuxi sesẽwo le sue ŋutɔ. Ame aɖewo ate ŋu axɔ dɔlékui sia eye woahaya dzesi aɖeke manɔmee.
Nukatae dɔlékui siwo ‘gbãa nu’ bɔ alea gbegbe?
Àte ŋu aɖo ŋku edzi be COVID-19 dɔlékuia ƒe vovototo vovovowo nɔ anyi. Vevietɔ esi
‘Omicron’ ƒe tɔtrɔ va la, ‘Breakthrough’ dɔlékuiwo ƒe xexlẽme dzi ɖe edzi. Nusitae nye be Omicron ƒe tɔtrɔ sia trɔ le mɔ aɖe nu be wòkaka kabakaba ŋutɔ eye ateŋu aɣla dɔlélenutsiŋutete si míexɔ tso míaƒe atikewo me vaseɖe afi aɖe. Kpɔe ɖa le susu me abe alesi fiafitɔ zãa ayemɔ vovovowo tsɔ gena ɖe aƒe aɖe me ene. Dɔlékuia hã dia ‘ayemɔ’ yeye mawo tɔgbe. Gake abe ema gbɔ kpɔnu ene la, woto atike yeye siwo doa ŋusẽ ame abe
‘Bivalent booster’ ene vɛ emegbe. Wokpɔa ame ta nyuie hã tso tɔtrɔ yeye siawo si me.
Nukawoe hea dɔlékui si ‘gbãa nu’ vɛ?
Susu vevi geɖewo li siwo tae ame aɖe ate ŋu axɔ dɔlékui si nye ‘breakthrough’:
- Ne wò dɔlélenutsiŋutete gbɔdzɔ: Wodzia ame aɖewo kple dɔlélenutsiŋutete si gbɔdzɔ. Azɔ hã, atikewɔwɔ abe kansa , nɔnɔmewo abe HIV , alo dɔléle bubu siwo nɔa anyi didi ene ate ŋu ana wòasesẽ na wò be nàwɔ avu kple dɔlékuiwo.Esia ate ŋu ana dɔlélenutsiŋutete hã nagbɔdzɔ, si ana amewo nate ŋu axɔ dɔlékuiwo.
- Ne dɔlékui ƒomevi yeye aɖe le ŋuwò : Abe alesi míeƒo nu tso eŋu va yi ene la, ƒomevi aɖewo te ŋu nɔa te ɖe atikewɔmɔnu nu vie. Gake ema mefia be viɖe aɖeke mele atikewɔmɔnua ŋu o. Atikea kple atike si doa ŋusẽe xɔxɔ ate ŋu akpɔ tawò tso nɔnɔme sesẽ siwo ƒomevi siawo ate ŋu ahe vɛ la me.
Ne ame aɖe si wodo atike na la dze dɔ la, ɖe wòate ŋu axɔ dɔa na ame bubua?
Ẽ, anya wɔ godoo. Nusiwo to vovo abe Omicron ene xɔa ame me ŋutɔ. Eyata ne wodo atike na wò bliboe gɔ̃ hã la, ne èxɔ dɔlékui aɖe si ‘trɔ asi le eŋu’ la, àte ŋu atsɔ dɔlékuia ayi na ame bubu kokoko.
Esia tae míegblɔna ɣesiaɣi be, ne wodo atike na wò hã la, be nàdo ametakpɔnu eye nàlé amewo dome didi me ɖe asi le dutoƒo xɔmenuwo me. Esia akpɔ wò kple amesiwo dome nèle ta.
Gake migaŋlɔ be o,
aʋawɔnu nyuitɔ kple ŋusẽtɔ kekeake si le mía si fifia be míatsɔ axe mɔ ɖe dɔléle sesẽwo nu eye míaɖe dɔlékuia ƒe kaka dzi akpɔtɔe nye COVID-19 ƒe atike la ŋutɔ. Ðe dɔlékui si nye ‘breakthrough’ ate ŋu ahe ‘Long COVID’ vɛa?
Gbã la, mina míalé ŋku ɖe nusi nye
'Long COVID' sia ŋu. Zi geɖe la, COVID-19 ƒe dzesiwo nɔa anyi abe kwasiɖa eve ene. Gake le ame aɖewo gome la, dzesi aɖewo nɔa anyi ɣleti geɖe ne dɔlékuia nu yi vɔ megbe. Le kpɔɖeŋu me,
Dzesi siawo nɔa anyi kwasiɖa 6 alo esi wu nenema eye woyɔnɛ be ‘Long COVID’ (si woyɔna le atikewɔwɔ me
be Post-Acute Sequelae of SARS-CoV-2 infection (PASC) ). Biabia si li fifiae nye be ɖe nɔnɔme sia ate ŋu adzɔ kple ‘Breakthrough’ dɔlékui aɖe hã.
Ŋuɖoɖoae nye ẽ, gake ƒã ŋutɔ. Nyatakakawo ɖee fia be ‘Breakthrough’ dɔlékui ʋɛ aɖewo koe va zu ‘Long COVID’, abe 10% ene. Atike xɔxɔ hã ɖea ‘Long COVID’ ƒe afɔkua dzi kpɔtɔna ŋutɔ.
Ðe wòle vevie be woaxɔ COVID-19 ƒe agbɔsɔsɔme si doa ŋusẽ amea?
Ẽ, keŋkeŋ. Dose si doa ŋusẽ ame le abe ‘ŋkuɖodzi’ na míaƒe dɔlélenutsiŋutete ene. Le ɣeyiɣi aɖe megbe la, ametakpɔkpɔ si atikewɔmɔnua nana ate ŋu aɖe akpɔtɔ vie. Woɖoe be booster la nagbugbɔ ametakpɔkpɔ ma aɖo afisi kɔkɔ wu. Edzraa ŋutilãa hã ɖo be wòawɔ avu kple dɔlékui ƒomevi yeyewo. Le aɖaŋuɖoɖo siwo lãmesẽnyawo gbɔ kpɔlawo na le Sri Lanka nu la, ele vevie ŋutɔ be nàxɔ atike si doa ŋusẽ ame si sɔ na wò. Tabla si le ete la ɖe dukɔwo dome aɖaŋuɖoɖo aɖewo fia. Wɔ ɖe lãmesẽdɔwɔla siwo le miaƒe nutoa me ƒe aɖaŋuɖoɖowo dzi ɣesiaɣi.
Le dedienɔnɔ ta la, nɔnɔme tɔxɛwo ŋutɔ me koe wokafua atike sia.
| Atikea ƒe ŋkɔ | Dzedze na booster dose | Ɣeyiɣi si woatsɔ axɔe |
|---|
| Pfizer-BioNTech ƒe dɔwɔwɔ | Amesiame si xɔ ƒe 12 kple edzivɔ | Ɣleti 2 le atikewɔmɔnu gbãtɔ siwo kplɔ wo nɔewo ɖo megbe |
| Egbe nu | Amesiame xɔ ƒe 5 kple edzivɔ | Ɣleti 5 le atike mamlɛtɔ si wozã vɔ megbe |
| Novavax ƒe dɔlékuiwutike | Abe atike si woatsɔ ado ŋusẽ amesiwo xɔ ƒe 18 kple edzivɔ ene | Ɣleti 6 le atikewɔmɔnu gbãtɔ siwo kplɔ wo nɔewo ɖo megbe |
| Johnson & Johnson ƒe agbalẽa me |
Ke ne 'Breakthrough COVID-19' le ŋunye ɖe?
Ne èxɔ wò atikewo katã, gake nèsusu be COVID-19 ƒe dzesiwo le ye ŋu la, mègatsi dzodzodzoe o eye nàwɔ nusiawo. 1.
Do dodokpɔ enumake: Do Rapid Antigen alo PCR dodokpɔ kaba ale si nàte ŋui. Nɔ aƒeme eye nànɔ adzɔge tso ame bubuwo gbɔ vaseɖe esime nàxɔ dodokpɔa kple emetsonuwo. 2.
Yɔ wò ɖɔkta: Ne wò dodokpɔ me tsonu nye ‘Positive’, si fia be dɔlékuia le ŋuwò la,
yɔ wò ƒomea ƒe ɖɔkta enumake.. Aɖo aɖaŋu kple atikewɔwɔ si hiã la wò. 3.
Te ɖa le ame bubuwo ŋu: Bia wò ɖɔkta ɣeyiɣi didi si wòle be nànɔ adzɔge tso ame bubuwo gbɔ. Wɔ ɖe eƒe aɖaŋuɖoɖoa dzi pɛpɛpɛ. 4.
Do motsyɔnu: Kpɔ egbɔ be yedo motsyɔnu ne èle ame bubuwo gbɔ le wò aƒeme (vevietɔ le ame ɖokui ɖeɖe ɖe aga me). Esia ate ŋu akpe ɖe ŋuwò nàxe mɔ ɖe dɔlélea ƒe kaka ɖe wò ƒomea me nu.
Ðo ŋku edzi be, eɖanye dzesiwo le ŋuwò alo mèkpɔe o, ne dodokpɔa ɖee fia be dɔlélea le ŋuwò la, nusi le dedie wue nye be nàƒo ka na wò ɖɔkta enumake aɖaɖo aɖaŋu na wò.
Gbedasi si Wotsɔ Yi Aƒeme
- COVID-19 ƒe atike la nye mɔ nyuitɔ si dzi woato akpɔ ame ta tso dɔléle sesẽwo, kɔdziyiyi, kple ku me.
- Esi wònye be atike aɖeke mewɔa dɔ 100% o ta la, mɔnukpɔkpɔ sue aɖe li be nàxɔ dɔa (breakthrough infection) ne èxɔ atike la gɔ̃ hã.
- Ne ‘breakthrough’ dɔlékui aɖe do mo ɖa hã la, dɔlélea ƒe sesẽme mesẽna kura o le atikewɔmɔnua ta.
- Ne dɔlékui aɖe si ‘trɔ asi le eŋu’ le ŋuwò la, àte ŋu akaka dɔlélea ɖe ame bubuwo me . Eyata yi edzi nàwɔ ɖe lãmesẽnyawo gbɔ kpɔkpɔ ƒe ɖoɖowo dzi.
- Ne èxɔ atike si doa ŋusẽ ame le ɣeyiɣi nyuitɔ dzi la, àte ŋu ana wò dɔlélenutsiŋutete nasɔ gbɔ.
- Ne èsusu be COVID-19 le ŋuwò alo nèkpɔe be COVID-19 le ŋuwò la, di aɖaŋuɖoɖo tso wò ɖɔkta gbɔ enumake .
Breakthrough COVID-19, COVID-19 vaccine, Covid booster, Long COVID, COVID-19 dɔlékui, Covid ƒe dzesiwo, COVID-19 Sri Lanka
💬 Comments (0)
No comments yet. Be the first to share your thoughts here.
Add Your Comment